ADA Scientific Sessions 2026 Abstract

BGE-102, a Novel NLRP3 Inhibitor, Demonstrated Robust Anti-Inflammatory Activity in an Ongoing Phase 1 Study in Healthy Volunteers and Participants with Obesity

By Lingling Chen, Aditi Deshpande, Taiz Salazar, Paul D. Rubin

Trial in peopleInterventions

The paper

Lingling Chen, Aditi Deshpande, Taiz Salazar, Paul D. Rubin

Emeryville

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1786-P

doi.org/10.2337/db26-1786-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Frontiers in Public Health2 Oct 2026
Exercise linked to reduced epicardial fat in older adults
Bulletin of Experimental Biology and Medicine2 Oct 2026
NLRP3 inflammasome activity shifts toward regulating cell fate in aged macrophages
Research Square4 Oct 2026
Midlife CRP rises linked to body fat rather than menopause stage